When to contact your GP or diabetes team : Persistent vomiting preventing fluid intake Severe abdominal pain, especially if radiating to the back (possible pancreatitis) Right upper abdominal pain, fever or jaundice (possible gallbladder problems) Signs of dehydration (dark urine, dizziness, reduced urination) Unexplained hypoglycaemia if on combination therapy New or worsening visual symptoms (especially if you have diabetic retinopathy) Allergic reactions (rash, swelling, breathing difficulties) Most patients tolerate GLP-1 medications well once past the initial adjustment period
Lixisenatide: evidence for its potential use in the treatment of type 2 diabetes
The Discovery of GLP-1 GLP-1 is part of the incretin family of hormones
Vadim Sherman, Houston Methodist Semaglutide and cardiovascular outcomes in obesity without diabetes, The New England Journal of Medicine (2023) What is clinically relevant weight loss for your patients and how can it be achieved
Personalized weight loss treatment, including a Compounded Sublingual Semaglutide 15mL
Take our Signature Shred for a spin
